Avanos Medical, Inc. (AVNS) Financials

$15.46

south_east
-$0.02 (-0.13%)
Day's range
$15.33
Day's range
$15.71
$1B$1B$800M$800M$600M$600M$400M$400M$200M$200M$0$0-$200M-$200MEarning2017201720182018201920192020202020212021202220222023202320%20%15%15%10%10%5%5%0%0%-5%-5%-10%-10%Profit Margin
Profit Margin
Revenue
Earnings

AVNS Income statement / Annual

Last year (2023), Avanos Medical, Inc.'s total revenue was $673.30 M, a decrease of 17.89% from the previous year. In 2023, Avanos Medical, Inc.'s net income was -$61.80 M. See Avanos Medical, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Operating Revenue $673.30 M $820.00 M $744.60 M $714.80 M $697.60 M $652.30 M $611.60 M $1.59 B $1.57 B $1.67 B
Cost of Revenue $293.60 M $370.00 M $380.30 M $341.50 M $295.40 M $261.40 M $274.70 M $1.03 B $1.04 B $1.12 B
Gross Profit $379.70 M $450.00 M $364.30 M $373.30 M $402.20 M $390.90 M $336.90 M $557.90 M $531.60 M $548.60 M
Gross Profit Ratio 0.56 0.55 0.49 0.52 0.58 0.6 0.55 0.35 0.34 0.33
Research and Development Expenses $27.20 M $30.60 M $32.30 M $34.90 M $37.70 M $41.80 M $38.20 M $41.10 M $32.30 M $33.60 M
General & Administrative Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $340.40 M $321.70 M $411.10 M $398.50 M $424.50 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $318.10 M $341.90 M $300.30 M $332.60 M $399.10 M $340.40 M $321.70 M $411.10 M $398.50 M $424.50 M
Other Expenses $30.20 M $3.50 M $22.80 M $51.90 M $21.10 M $8.20 M $20.10 M $18.30 M $4.50 M -$3.80 M
Operating Expenses $375.50 M $376.00 M $355.40 M $419.40 M $457.90 M $390.40 M $380.00 M $470.50 M $435.30 M $454.30 M
Cost And Expenses $669.10 M $746.00 M $735.70 M $760.90 M $753.30 M $651.80 M $654.70 M $1.50 B $1.48 B $1.58 B
Interest Income $2.90 M $1.20 M $200,000.00 $1.20 M $6.70 M $7.80 M $2.50 M $600,000.00 $300,000.00 $2.90 M
Interest Expense $15.00 M $10.00 M $3.30 M $15.60 M $15.00 M $26.40 M $31.60 M $32.70 M $33.10 M $6.00 M
Depreciation & Amortization $46.10 M $41.10 M $38.30 M $42.90 M $36.90 M $33.50 M $40.00 M $41.00 M $65.40 M $85.40 M
EBITDA $50.60 M $77.80 M $8.90 M -$2.00 M -$12.10 M $65.70 M -$600,000.00 -$65.50 M -$76.50 M $179.70 M
EBITDA Ratio 0.08 0.15 0.06 -0 -0.02 0.06 0.03 0.1 0.1 0.11
Operating Income Ratio 0.01 0.09 0.01 -0.06 -0.08 0 -0.07 0.05 -0.24 0.06
Total Other Income/Expenses Net -$12.10 M -$8.80 M $44.80 M -$14.40 M -$8.30 M -$18.60 M -$29.10 M -$32.10 M -$274.80 M -$3.10 M
Income Before Tax -$7.90 M $65.20 M $5.80 M -$60.50 M -$64.00 M -$18.10 M -$72.20 M $55.30 M -$410.50 M $91.20 M
Income Before Tax Ratio -0.01 0.08 0.01 -0.08 -0.09 -0.03 -0.12 0.03 -0.26 0.05
Income Tax Expense $2.00 M $14.70 M $600,000.00 -$33.30 M -$18.10 M -$9.60 M -$40.10 M $15.50 M $15.80 M $64.10 M
Net Income -$61.80 M $50.50 M $6.30 M -$27.20 M -$45.90 M $57.50 M $79.30 M $39.80 M -$426.30 M $27.10 M
Net Income Ratio -0.09 0.06 0.01 -0.04 -0.07 0.09 0.13 0.02 -0.27 0.02
EPS -1.33 1.08 0.13 -0.57 -0.96 1.22 1.69 0.85 -9.15 0.58
EPS Diluted -1.33 1.07 0.13 -0.57 -0.96 1.22 1.69 0.85 -9.15 0.58
Weighted Average Shares Out $46.60 M $46.90 M $48.10 M $47.80 M $47.60 M $47.20 M $46.52 M $46.60 M $46.59 M $46.54 M
Weighted Average Shares Out Diluted $46.60 M $47.30 M $48.60 M $47.80 M $47.60 M $47.20 M $46.80 M $47.00 M $46.59 M $46.54 M
Link